Missense mutations in SCN9A have been associated to a spectrum of painful conditions in humans [3], including inherited erythromelalgia (IEM), [4–13], paroxysmal extreme pain disorder (PEPD) [14–17], and small fibre neuropathy (SFN) [18, 19]. This evidence concerns the gene SCN9A and paroxysmal extreme pain disorder.